Eiman Ibrahim

I am responsible for coordination of two research clinical trials, First one studying the mechanism behind the development of chemotherapy induced peripheral neuropathy and cognitive impairment in breast cancer patients. While in the second study we want to detect a number of blood bio-marker in newly diagnosed breast cancer patients. In the meantime, I am working toward completion of a systematic review on cognitive function in breast cancer survivors after taxanes.